Good AI Capital

Mekonos Inc. is a technology company based in San Francisco, California, focused on the design, development, and production of gene and cell therapies. Founded in 2017, Mekonos has developed a proprietary cell-engineering platform that utilizes scalable silicon technology and an integrated system-on-a-chip. This platform enables the creation of predictive models for drug discovery and development, as well as a silicon chip automated architecture for genome editing. The company's innovative MEMS technology allows for the precise control of individual nanoneedles to inject single cells in parallel, facilitating the industrialization of engineered therapies for genetic diseases, including cancers. By providing a reliable and reusable manufacturing system, Mekonos aims to enable healthcare providers to deliver a diverse range of therapeutic molecules across various primary cell types.

Playco Global, Inc. is an instant-play gaming company that specializes in developing a browser-based streaming game engine, enabling multiplayer games that people can enjoy together without the need for downloads. Founded in 2010 and based in Mountain View, California, with additional offices in San Francisco, Tokyo, and Seoul, the company creates games, backend infrastructure, and analytics, distributing its offerings across various gaming platforms. Playco collaborates with a diverse network of partners, ranging from established technology and social media giants to innovative startups, to enhance its gaming experiences. The company's focus on accessibility allows users to engage in advanced gaming on popular social and messenger platforms using basic setups.

Mekonos Inc. is a technology company based in San Francisco, California, focused on the design, development, and production of gene and cell therapies. Founded in 2017, Mekonos has developed a proprietary cell-engineering platform that utilizes scalable silicon technology and an integrated system-on-a-chip. This platform enables the creation of predictive models for drug discovery and development, as well as a silicon chip automated architecture for genome editing. The company's innovative MEMS technology allows for the precise control of individual nanoneedles to inject single cells in parallel, facilitating the industrialization of engineered therapies for genetic diseases, including cancers. By providing a reliable and reusable manufacturing system, Mekonos aims to enable healthcare providers to deliver a diverse range of therapeutic molecules across various primary cell types.

UpLift, Inc. is a digital lending platform that specializes in providing Buy Now, Pay Later solutions for travel-related expenses. Founded in 2014 and based in Menlo Park, California, the company offers loans and credit facilities that allow consumers to book holidays and travel experiences while paying in manageable monthly installments. Through partnerships with over 100 leading travel brands, UpLift delivers personalized and flexible payment options, enabling customers to better manage their budgets and enhancing their ability to travel. The platform serves to increase conversion rates and customer lifetime value for its merchant partners, making travel more accessible and affordable.